Talking therapy shows promise for trauma in people with learning disabilities

NCT ID NCT06934109

Completed Symptom relief Sponsor: University of Nottingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an adapted form of Narrative Exposure Therapy (NET) is acceptable and helpful for adults with mild learning disabilities who have experienced trauma. Thirteen participants completed the therapy, which involved talking through their life events in a structured way. Researchers measured trauma symptoms weekly and gathered feedback from participants and their carers after the therapy ended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Narrative Exposure Therapy (NET) - a talking therapy adapted for people with learning disabilities
What this could lead to: If this therapy works well, it could offer a practical, non-drug way to help people with learning disabilities recover from trauma.
What could go wrong: This is a very small study (13 people) with no comparison group, so results may not apply widely. The therapy is also intensive (12 sessions) and requires travel to a clinic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTELLECTUAL DISABILITY, MILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

follicular lymphoma intellectual disability learning disability post-traumatic stress disorder Psychological Trauma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTELLECTUAL DISABILITY, MILD LEARNING DISABILITY PTSD TRAUMA, PSYCHOLOGICAL

Contacts and locations

Locations

Nottinghamshire Healthcare NHS Foundation Trust

Nottingham, NG3 6AA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.